Thoratec Surpasses 10000 HeartMate II® Implants WorldwideSacramento Bee"Every year, millions of people worldwide develop chronic heart failure, and many will progress to an advanced, debilitating stage of the disease," said Gary Burbach, Pre…
EHRs Often Lack Clinical Best Practices – InformationWeek
EHRs Often Lack Clinical Best PracticesInformationWeekClinical decision support vendor Zynx Health finds electronic health records fall short in treating heart failure, pneumonia. By Neil Versel InformationWeek Hospitals with electronic health records …
Young kidney transplant recipient from Wallington's artwork picked for calendar cover
Wallington youngster wins contest.
SPK Transplants May Offer No Advantage for Type 2 Diabetes – Renal and Urology News
SPK Transplants May Offer No Advantage for Type 2 DiabetesRenal and Urology NewsSimultaneous pancreas-kidney (SPK) transplantation offers no patient or survival advantage over deceased-donor kidney transplantation alone (DDKA) for selected patients wit…
Orgenesis Inc. Appoints Biotech Veteran to Board of Directors – SYS-CON Media (press release)
Orgenesis Inc. Appoints Biotech Veteran to Board of DirectorsSYS-CON Media (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the ri…
Orgenesis Inc. Appoints Biotech Veteran to Board of Directors – MarketWatch (press release)
Orgenesis Inc. Appoints Biotech Veteran to Board of DirectorsMarketWatch (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk…
Role of Screening, Monitoring in Early Kidney Disease Unclear – U.S. News & World Report
Role of Screening, Monitoring in Early Kidney Disease UnclearU.S. News & World ReportBy Serena Gordon TUESDAY, April 17 (HealthDay News) — At least one in 10 US adults is estimated to have chronic kidney disease, but whether screening and monitoring p…
Joe Huiras Benefit to be held April 28 – Sleepy Eye Herald Dispatch
Joe Huiras Benefit to be held April 28Sleepy Eye Herald DispatchA benefit is being held to raise money to help with medical bills for Joe's stem cell transplant which is scheduled to take place on May 7. Joe, a 2002 graduate of St. Mary's Schoo…
Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in … – MarketWatch (press release)
Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in …MarketWatch (press release)… models have demonstrated PLX cells are also potentially effective for other ischemic and inflammatory indications such as heart disease, muscle injur…
Opsona Therapeutics announces the issuance of new patent from the European … – MarketWatch (press release)
Opsona Therapeutics announces the issuance of new patent from the European …MarketWatch (press release)TLR-2 plays an important role in the induction and progression of a number of non-pathogen associated inflammatory conditions including ischemia re…